CCCC C4 Therapeutics, Inc.

Fundamentals / CIK 0001662579 / USD

C4 Therapeutics, Inc. reported $32.28M in revenue and a net loss of $91.09M for the trailing twelve months ended September 30, 2026 (down 24.6% year over year), with a -315.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CCCC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$59.12M$29.56M$0-$127.8MFY 2019 Net Income: -$34.10M2019FY 2020 Net Income: -$66.33M2020FY 2021 Revenue: $45.78MFY 2021 Net Income: -$83.89M2021FY 2022 Revenue: $31.10MFY 2022 Net Income: -$128.2M2022FY 2023 Revenue: $20.76MFY 2023 Net Income: -$132.5M2023FY 2024 Revenue: $35.58MFY 2024 Net Income: -$105.3M2024FY 2025 Revenue: $35.95MFY 2025 Net Income: -$105.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $35.95M $35.58M $20.76M $31.10M $45.78M -- --
Research & Development $104.2M $110.6M $117.7M $117.8M $94.67M $78.44M $48.06M
Total Operating Expenses $151.2M $155.2M $159.8M $160.6M $127.9M $93.64M $56.83M
Operating Income -$115.2M -$119.6M -$139.0M -$129.5M -$82.13M -$60.45M -$35.45M
EBITDA -$113.3M -$117.8M -$137.2M -$127.9M -$80.64M -$58.83M -$33.86M
Income Before Tax -$104.9M -$105.2M -$131.2M -$128.2M -$83.89M -$66.96M -$33.30M
Income Tax Expense $121K $131K $1.28M $0 $0 -$626K $804K
Net Income -$105.0M -$105.3M -$132.5M -$128.2M -$83.89M -$66.33M -$34.10M
Basic EPS -$1.27 -$1.52 -$2.67 -$2.62 -$1.82 -$5.83 -$31.03
Diluted EPS -$1.27 -$1.52 -$2.67 -$2.62 -$1.82 -$5.83 -$31.03
Basic Shares Outstanding 82.9M 69.4M 49.6M 48.9M 46.0M 11.4M 1.4M
Diluted Shares Outstanding 82.9M 69.4M 49.6M 48.9M 46.0M 11.4M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $8.47M $6.64M $6.15M $11.02M $11.23M $6.46M $7.24M $5.18M
Research & Development $24.80M $24.47M $24.61M $24.98M $25.99M $26.20M $27.07M $32.51M
Total Operating Expenses $33.06M $33.06M $33.94M $34.16M $45.64M $34.96M $36.40M $42.89M
Operating Income -$24.60M -$26.42M -$27.79M -$23.14M -$34.41M -$28.50M -$29.16M -$37.71M
EBITDA -$24.28M -$26.13M -$27.38M -$22.77M -$33.95M -$27.89M -$28.71M -$37.34M
Income Before Tax -- -- -- -$20.36M -$32.17M -$26.02M -$26.32M -$34.44M
Income Tax Expense $0 $0 $0 $121K $0 $0 $0 $131K
Net Income -$21.84M -$23.64M -$25.13M -$20.49M -$32.17M -$26.02M -$26.32M -$34.57M
Basic EPS -$0.16 -$0.18 -$0.20 -- -$0.44 -$0.37 -$0.37 --
Diluted EPS -$0.16 -$0.18 -$0.20 -- -$0.44 -$0.37 -$0.37 --
Basic Shares Outstanding 136.1M 130.7M 126.1M -- 72.6M 71.0M 70.8M --
Diluted Shares Outstanding 136.1M 130.7M 126.1M -- 72.6M 71.0M 70.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $74.60M $55.50M $126.6M $29.75M $76.12M $181.7M $90.55M
Short-Term Investments -- -- -- -- $233.2M $190.0M --
Cash & Short-Term Investments $297.1M $267.3M $281.7M $337.1M $451.5M $371.7M $90.55M
Accounts Receivable, Net $2.40M $3.10M $11.80M $1.47M $5.72M $4.48M $4.62M
Total Current Assets $258.1M $257.8M $271.2M $287.6M $325.7M $381.0M $96.77M
Property, Plant & Equipment, Net $4.74M $5.84M $7.13M $7.40M $3.11M $3.32M $4.46M
Long-Term Investments -- -- -- -- $142.2M -- --
Other Non-Current Assets $3.68M $2.65M $2.72M $1.53M $544K -- --
Total Non-Current Assets $101.0M $91.83M $105.3M $143.3M $181.1M $19.13M $21.49M
Total Assets $359.1M $349.6M $376.5M $430.8M $506.8M $400.1M $118.3M
Accounts Payable $858K $1.33M $1.45M $1.17M $4.51M $5.68M $5.38M
Short-Term Debt -- -- $0 $2.29M $0 -- --
Deferred Revenue (Current) $12.49M $18.71M $15.47M $16.62M $31.80M $27.60M $20.70M
Other Current Liabilities $1.40M $1.87M $2.04M $3.11M $413K $469K $280K
Total Current Liabilities $33.03M $45.18M $42.77M $44.55M $51.25M $43.85M $33.64M
Long-Term Debt -- -- $0 $9.20M $10.77M $10.05M --
Deferred Revenue (Non-Current) $15.84M $28.46M $21.81M $16.89M $24.37M $53.62M $72.72M
Total Non-Current Liabilities $69.46M $88.44M $87.57M $97.06M $65.91M $75.50M $85.59M
Total Liabilities $102.5M $133.6M $130.3M $141.6M $117.2M $119.3M $119.2M
Total Debt (incl. Leases) $59.98M $65.76M $70.98M $87.15M $42.88M $22.92M $13.75M
Common Stock $9.0K $7.0K $6.0K $5.0K $5.0K $4.0K $1.0K
Retained Earnings -$738.7M -$633.7M -$528.4M -$395.9M -$267.7M -$183.8M -$117.5M
Accumulated Other Comp. Income $50K $53K -$127K -$4.14M -$775K $13K --
Total Stockholders' Equity $256.6M $216.0M $246.1M $289.2M $389.6M $280.8M -$112.0M
Total Equity $256.6M $216.0M $246.1M $289.2M $389.6M $280.8M -$112.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $32.42M $78.61M $61.27M $74.60M $58.81M $78.16M $51.29M $55.50M
Cash & Short-Term Investments $274.7M $300.4M $268.3M $297.1M $199.8M $223.0M $234.7M $267.3M
Accounts Receivable, Net $1.41M $1.33M $2.88M $2.40M $6.54M $2.16M $8.03M $3.10M
Total Current Assets $214.5M $262.9M $245.4M $258.1M $206.9M $224.7M $232.5M $257.8M
Property, Plant & Equipment, Net $3.83M $4.15M $4.49M $4.74M $5.13M $5.54M $5.48M $5.84M
Other Non-Current Assets $4.57M $4.49M $3.87M $3.68M $211K $178K $2.56M $2.65M
Total Non-Current Assets $117.3M $96.50M $83.49M $101.0M $58.62M $71.80M $86.99M $91.83M
Total Assets $331.8M $359.4M $328.9M $359.1M $265.5M $296.5M $319.5M $349.6M
Accounts Payable $963K $1.12M $773K $858K $1.33M $2.22M $683K $1.33M
Deferred Revenue (Current) $19.52M $26.66M $10.12M $12.49M $17.13M $22.62M $21.59M $18.71M
Other Current Liabilities $989K $995K $1.57M $1.40M $1.75M $1.58M $1.88M $1.87M
Total Current Liabilities $41.46M $48.25M $27.25M $33.03M $35.95M $44.46M $40.82M $45.18M
Deferred Revenue (Non-Current) $13.77M $13.71M $15.44M $15.84M $19.89M $21.15M $25.12M $28.46M
Total Non-Current Liabilities $62.17M $63.89M $67.36M $69.46M $75.14M $78.01M $83.56M $88.44M
Total Liabilities $103.6M $112.1M $94.61M $102.5M $111.1M $122.5M $124.4M $133.6M
Total Debt (incl. Leases) $55.25M $56.86M $58.45M $59.98M $61.46M $62.92M $64.37M $65.76M
Common Stock $13K $12K $10K $9.0K $7.0K $7.0K $7.0K $7.0K
Retained Earnings -$809.3M -$787.5M -$763.8M -$738.7M -$718.2M -$686.0M -$660.0M -$633.7M
Accumulated Other Comp. Income -$1.06M -$444K -$322K $50K $87K -$30K $43K $53K
Total Stockholders' Equity $228.2M $247.3M $234.2M $256.6M $154.4M $174.1M $195.1M $216.0M
Total Equity $228.2M $247.3M $234.2M $256.6M $154.4M $174.1M $195.1M $216.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$105.0M -$105.3M -$132.5M -$128.2M -$83.89M -$66.33M -$34.10M
Depreciation & Amortization $1.96M $1.82M $1.88M $1.68M $1.49M $1.62M $1.59M
Stock-Based Compensation $19.10M $29.66M $27.23M $30.02M $21.51M $3.43M $1.64M
Change in Receivables $701K $8.70M -$10.33M $4.24M -$1.23M $139K $81.81M
Change in Payables -$468K -$119K $273K -$3.33M -$1.18M $467K $4.23M
Operating Cash Flow -$98.69M -$65.16M -$106.8M -$105.9M -$86.97M -$67.25M $55.61M
Capital Expenditure -$607K -$180K -$1.71M -$5.50M -$1.28M -$650K -$1.35M
Free Cash Flow -$99.30M -$65.34M -$108.5M -$111.4M -$88.24M -$67.90M $54.27M
Purchases of Investments -$227.1M -$284.3M -$129.9M -$219.5M -$537.7M -$293.9M -$79.00M
Investing Cash Flow -$8.60M -$51.27M $158.3M $58.42M -$189.3M -$190.5M -$1.62M
Common Stock Issued -- -- $57.67M $0 -- -- --
Share Repurchases -$193K -$194K -$110K $0 -- -$194K -$30K
Financing Cash Flow $126.4M $45.34M $45.49M $1.15M $171.4M $348.9M $244K
Net Change in Cash $19.10M -$71.09M $97.00M -$46.37M -$104.9M $91.18M $54.24M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.84M -$23.64M -$25.13M -$20.49M -$32.17M -$26.02M -$26.32M -$34.57M
Depreciation & Amortization $320K $292K $404K $377K $460K $615K $456K $364K
Stock-Based Compensation $2.98M $3.04M $2.67M $4.01M $4.59M $4.99M $5.51M $8.23M
Change in Receivables -$71K $1.55M -$482K $4.14M -$4.34M $5.83M -$4.93M $7.24M
Change in Payables -$158K $348K -$85K -$472K -$885K $1.53M -$645K -$176K
Operating Cash Flow -$25.97M -$1.57M -$29.94M -$22.14M -$31.21M -$12.06M -$33.28M -$17.93M
Capital Expenditure $0 -$37K -$64K -$11K -$411K -$185K $0 $4.0K
Free Cash Flow -$25.97M -$1.61M -$30.01M -$22.16M -$31.62M -$12.24M -$33.28M -$17.93M
Purchases of Investments -$68.63M -$70.83M -$40.81M -$133.1M -$46.68M -$21.68M -$25.64M -$40.78M
Investing Cash Flow -$20.58M -$14.81M $16.15M -$80.73M $4.09M $38.92M $29.12M $13.67M
Share Repurchases -$39K $0 -$200K -$14K -$24K $0 -$155K $0
Financing Cash Flow $359K $33.73M $462K $118.7M $7.77M $0 -$46K $112K
Net Change in Cash -$46.19M $17.34M -$13.33M $15.79M -$19.35M $26.86M -$4.21M -$4.15M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -320.5% -336.1% -669.8% -416.6% -179.4% -- --
Net Profit Margin -292.1% -296.0% -638.3% -412.2% -183.2% -- --
Return on Equity (ROE) -40.9% -48.8% -53.8% -44.3% -21.5% -23.6% --
Return on Assets (ROA) -29.2% -30.1% -35.2% -29.8% -16.6% -16.6% -28.8%
Current Ratio 7.81x 5.71x 6.34x 6.46x 6.36x 8.69x 2.88x
Quick Ratio 9.07x 5.99x 6.86x 7.60x 8.92x 8.58x 2.83x
Debt to Equity 0.23x 0.30x 0.29x 0.30x 0.11x 0.08x --
Revenue Growth (YoY) +1.0% +71.4% -33.3% -32.1% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -220.9% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -225.1% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -315.9% -319.0% -326.6% -320.5% -431.1% -361.0% -293.0% -336.1%
Net Profit Margin -282.2% -289.4% -297.8% -292.1% -395.5% -325.9% -259.6% -296.0%
Return on Equity (ROE) -39.9% -41.0% -44.3% -40.9% -77.1% -64.1% -52.9% -48.8%
Return on Assets (ROA) -27.5% -28.2% -31.6% -29.2% -44.9% -37.6% -32.3% -30.1%
Current Ratio 5.17x 5.45x 9.00x 7.81x 5.76x 5.06x 5.70x 5.71x
Quick Ratio 6.66x 6.25x 9.95x 9.07x 5.74x 5.06x 5.95x 5.99x
Debt to Equity 0.24x 0.23x 0.25x 0.23x 0.40x 0.36x 0.33x 0.30x
Revenue Growth (YoY) -24.6% +2.8% -15.0% +112.8% -26.9% -46.2% +138.2% +58.8%
Source: SEC EDGAR CompanyFacts (CIK 0001662579) · from September 30, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:38 UTC · Open in terminal